Herein, by blocking plasminogen receptor function of cell surface ENO1, we hypothesized HL217 may provide beneficial effects in pulmonary fibrosis via its ability to inhibit the ENO1/uPAR/plasmin axis, which is crucial for the migration of inflammatory monocytes and fibroblasts and their ensuing fibrotic activities. Here, PLG is linked to pulmonary fibrosis.